Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009" and HR1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR1260 "The Patent Reform Act of 2009"
Coverage and payment issues for pharmaceuticals under consideration for draft legislation for healthcare reform; issues related to the importation of prescription drugs in amendments to the draft legislation "Affordable Health Choices Act"; issues related to a regulatory pathway and reimburesment for follow on biologics, including such provisions in HR 1548 "Pathway for Biosimilars Act"; issues related to awareness of the company's Access to Medicines Program; all provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"; general issues related to the Medicare Part D program
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2009 · fourth_quarter · Q4
Provisions and issues related to patient access to and the coverage, payment and pricing of pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to cancer awareness and access to treatment, issues and provisions related to the 340B federal Safety Net Drug Pricing Program, issues and provisions related to comparative effectiveness, and issues and provisions related to the Independent Medicare Advisory Committee in HR3590"The Patient Protection and Affordable Care Act." All provisions of SAmdt2952 to HR3590. General issues related to the Medicare Part D program including patient access to pharmaceuticals, issues related to awareness of atrial fibrillation and access to treatment, issues related to cancer awareness and access to treatment; and H Res 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month' and 'National DVT Screening Day' and supporting efforts to educate the public about deep vein thrombosis, in memory of former Representative Jennifer Dunn."
Source: Senate LDA
Protecting Consumer Access to Generic Drugs Act of 2009
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009" and HR1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR1260 "The Patent Reform Act of 2009"
Comparative Effectiveness Research Act of 2009
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Provisions and issues related to coverage and payment pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to the importation of prescription drugs, issues related to cancer awareness and access to treatment, issues related to the coordination of care, and issues related to the 340B federal Safety Net Drug Pricing Program including such provisions included or under consideration in draft health care reform legislation "America's Healthy Future Act," and in HR3200 "America's Affordable Health Choices Act," and S1679 "Affordable Health Choices Act"; General issues related to the Medicare Part D program and issues related to awareness of atrial fibrillation and access to treatment.; All provisions of HR2502 "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes"; All provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"
America's Affordable Health Choices Act of 2009
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Provisions and issues related to coverage and payment pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to the importation of prescription drugs, issues related to cancer awareness and access to treatment, issues related to the coordination of care, and issues related to the 340B federal Safety Net Drug Pricing Program including such provisions included or under consideration in draft health care reform legislation "America's Healthy Future Act," and in HR3200 "America's Affordable Health Choices Act," and S1679 "Affordable Health Choices Act"; General issues related to the Medicare Part D program and issues related to awareness of atrial fibrillation and access to treatment.; All provisions of HR2502 "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes"; All provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"
Supporting the goals and ideals of "Deep Vein Thrombosis Awareness Month" and "National DVT Screening Day" and supporting efforts to educate the public about deep vein thrombosis, in memory of former Representative Jennifer Dunn.
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Coverage and payment issues for pharmaceuticals under consideration for draft legislation for healthcare reform; issues related to the importation of prescription drugs in amendments to the draft legislation "Affordable Health Choices Act"; issues related to a regulatory pathway and reimburesment for follow on biologics, including such provisions in HR 1548 "Pathway for Biosimilars Act"; issues related to awareness of the company's Access to Medicines Program; all provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"; general issues related to the Medicare Part D program
Supporting the goals and ideals of "Deep Vein Thrombosis Awareness Month" and "National DVT Screening Day" and supporting efforts to educate the public about deep vein thrombosis, in memory of former Representative Jennifer Dunn.
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Provisions and issues related to coverage and payment pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to the importation of prescription drugs, issues related to cancer awareness and access to treatment, issues related to the coordination of care, and issues related to the 340B federal Safety Net Drug Pricing Program including such provisions included or under consideration in draft health care reform legislation "America's Healthy Future Act," and in HR3200 "America's Affordable Health Choices Act," and S1679 "Affordable Health Choices Act"; General issues related to the Medicare Part D program and issues related to awareness of atrial fibrillation and access to treatment.; All provisions of HR2502 "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes"; All provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"
Supporting the goals and ideals of "Deep Vein Thrombosis Awareness Month" and "National DVT Screening Day" and supporting efforts to educate the public about deep vein thrombosis, in memory of former Representative Jennifer Dunn.
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Provisions and issues related to patient access to and the coverage, payment and pricing of pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to cancer awareness and access to treatment, issues and provisions related to the 340B federal Safety Net Drug Pricing Program, issues and provisions related to comparative effectiveness, and issues and provisions related to the Independent Medicare Advisory Committee in HR3590"The Patient Protection and Affordable Care Act." All provisions of SAmdt2952 to HR3590. General issues related to the Medicare Part D program including patient access to pharmaceuticals, issues related to awareness of atrial fibrillation and access to treatment, issues related to cancer awareness and access to treatment; and H Res 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month' and 'National DVT Screening Day' and supporting efforts to educate the public about deep vein thrombosis, in memory of former Representative Jennifer Dunn."
Provisions and issues related to coverage and payment pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to the importation of prescription drugs, issues related to cancer awareness and access to treatment, issues related to the coordination of care, and issues related to the 340B federal Safety Net Drug Pricing Program including such provisions included or under consideration in draft health care reform legislation "America's Healthy Future Act," and in HR3200 "America's Affordable Health Choices Act," and S1679 "Affordable Health Choices Act"; General issues related to the Medicare Part D program and issues related to awareness of atrial fibrillation and access to treatment.; All provisions of HR2502 "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes"; All provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"
Preserve Access to Affordable Generics Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009" and HR1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR1260 "The Patent Reform Act of 2009"
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009" and HR1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR1260 "The Patent Reform Act of 2009"
American Middle Class Tax (AMT) Relief Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Provisions and issues related to patient access to and the coverage, payment and pricing of pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to cancer awareness and access to treatment, issues and provisions related to the 340B federal Safety Net Drug Pricing Program, issues and provisions related to comparative effectiveness, and issues and provisions related to the Independent Medicare Advisory Committee in HR3590"The Patient Protection and Affordable Care Act." All provisions of SAmdt2952 to HR3590. General issues related to the Medicare Part D program including patient access to pharmaceuticals, issues related to awareness of atrial fibrillation and access to treatment, issues related to cancer awareness and access to treatment; and H Res 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month' and 'National DVT Screening Day' and supporting efforts to educate the public about deep vein thrombosis, in memory of former Representative Jennifer Dunn."
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call To Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.; issues related to the 340B federal drug pricing program
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis awareness; issues related to follow-on biologics included all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call to Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System; issues related to the 340B federal drug pricing program.
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis awareness; issues related to follow-on biologics including all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S 567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR 4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
Social Security Trust Funds Investment Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call To Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.; issues related to the 340B federal drug pricing program
Social Security Trust Funds Investment Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call to Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System; issues related to the 340B federal drug pricing program.
Biologics Price Competition and Innovation Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis awareness; issues related to follow-on biologics including all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S 567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR 4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
Biologics Price Competition and Innovation Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call To Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.; issues related to the 340B federal drug pricing program
Biologics Price Competition and Innovation Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis awareness; issues related to follow-on biologics included all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
Biologics Price Competition and Innovation Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call to Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System; issues related to the 340B federal drug pricing program.
National Defense Authorization Act for Fiscal Year 2008
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call To Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.; issues related to the 340B federal drug pricing program
National Defense Authorization Act for Fiscal Year 2008
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis awareness; issues related to follow-on biologics including all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S 567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR 4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
National Defense Authorization Act for Fiscal Year 2008
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call to Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System; issues related to the 340B federal drug pricing program.
National Defense Authorization Act for Fiscal Year 2008
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis awareness; issues related to follow-on biologics included all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call to Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System; issues related to the 340B federal drug pricing program.
Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call To Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.; issues related to the 340B federal drug pricing program
Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to follow on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Administration Revitalization Act" and HR3580, "The Food and Drug Administration Amendment Act of 2007," and HR3610 "Food and Drug Import Safety Act of 2007"; HR1038 "Access to Life-Saving Medicine Act" and S1695 "Biologics Price Competition and Innovation Act of 2007" All provisions.
S1145 and HR1908 "Patent Reform Act of 2007" (all provisions)
S1145 and HR 1908, "The Patent Reform Act of 2007" All provisions
Investment in America Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
HR2138 "Investment in America Act of 2007" (all provisions)
Food and Drug Administration Amendments Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to follow on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Revitalization Act of 2007" and HR2900 "The Food and Drug Administration Amendments Act of 2007"
Food and Drug Administration Amendments Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to follow on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Administration Revitalization Act" and HR3580, "The Food and Drug Administration Amendment Act of 2007," and HR3610 "Food and Drug Import Safety Act of 2007"; HR1038 "Access to Life-Saving Medicine Act" and S1695 "Biologics Price Competition and Innovation Act of 2007" All provisions.
Food and Drug Import Safety Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to follow on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Administration Revitalization Act" and HR3580, "The Food and Drug Administration Amendment Act of 2007," and HR3610 "Food and Drug Import Safety Act of 2007"; HR1038 "Access to Life-Saving Medicine Act" and S1695 "Biologics Price Competition and Innovation Act of 2007" All provisions.
Food and Drug Import Safety Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
H.R.3610, "Food and Drug Import Safety Act of 2007"; S.242, H.R.380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2638, "Department of Homeland Security Appropriations Act, 2008"; H.AMDT 734 to HR3161 and S1859 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to importation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
H.R.3610, "Food and Drug Import Safety Act of 2007"; S.242, H.R.380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2638, "Department of Homeland Security Appropriations Act, 2008"; H.AMDT 734 to HR3161 and S1859 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to importation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public
Medicare Prescription Drug Price Negotiation Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
coding and reimbursement or coverage issues for Medicare Part B products and Medicare Part D services, preventative health screenings and assessments, and obesity drugs; issues related to DVT prevention and awareness, including draft legislation "Deep Vein Thrombosis Prevention Act of 2007" ; issues related to osteoporosis prevention and awareness. HR4 and S3 "Medicare Prescription Drug Price Negotiation Act Of 2007" (All Provisions); issues and provisions related to the closure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007" and S1607 "The Children's Health Insurance Program Reauthorization Act of 2007";
Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2008
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
HR4104 and HR2642, "Military Construction and Veterans Affairs and Related Agencies Appropriations Act of 2008" (provisions related to the quality of healthcare delivered by the Veterans Health Administration)
S1145 and HR1908 "Patent Reform Act of 2007" (all provisions)
S1145 and HR 1908, "The Patent Reform Act of 2007" All provisions
Currency Exchange Rate Oversight Reform Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
coding and reimbursement or coverage issues for Medicare Part B products and Medicare Part D services, preventative health screenings and assessments, and obesity drugs; issues related to DVT prevention and awareness, including draft legislation "Deep Vein Thrombosis Prevention Act of 2007" ; issues related to osteoporosis prevention and awareness. HR4 and S3 "Medicare Prescription Drug Price Negotiation Act Of 2007" (All Provisions); issues and provisions related to the closure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007" and S1607 "The Children's Health Insurance Program Reauthorization Act of 2007";
Currency Exchange Rate Oversight Reform Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues and provisions related to the closure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007 and S1607, "The Children's Health Insurance Program Reauthorization Act of 2007." coding and reimbursement or coverage issues for Medicare
Foreign Investment and National Security Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the reform of the CFIUS review process, including HR556 "National Security Foreign Investment Reform and Strengthened Transparency" and S1610 "Foreign Investment and National Security Act of 2007"
Biologics Price Competition and Innovation Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to follow on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Administration Revitalization Act" and HR3580, "The Food and Drug Administration Amendment Act of 2007," and HR3610 "Food and Drug Import Safety Act of 2007"; HR1038 "Access to Life-Saving Medicine Act" and S1695 "Biologics Price Competition and Innovation Act of 2007" All provisions.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
H.R.3610, "Food and Drug Import Safety Act of 2007"; S.242, H.R.380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2638, "Department of Homeland Security Appropriations Act, 2008"; H.AMDT 734 to HR3161 and S1859 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to importation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
H.R.3610, "Food and Drug Import Safety Act of 2007"; S.242, H.R.380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2638, "Department of Homeland Security Appropriations Act, 2008"; H.AMDT 734 to HR3161 and S1859 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to importation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public
Medicare Prescription Drug Price Negotiation Act of 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
coding and reimbursement or coverage issues for Medicare Part B products and Medicare Part D services, preventative health screenings and assessments, and obesity drugs; issues related to DVT prevention and awareness, including draft legislation "Deep Vein Thrombosis Prevention Act of 2007" ; issues related to osteoporosis prevention and awareness. HR4 and S3 "Medicare Prescription Drug Price Negotiation Act Of 2007" (All Provisions); issues and provisions related to the closure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007" and S1607 "The Children's Health Insurance Program Reauthorization Act of 2007";
National Defense Authorization Act for Fiscal Year 2008
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
HR1585 and S567, "National Defense Authorization Act for FY2008" ; HR3222 and HR2764, "Department of Defense Appropriations Act, 2008: provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.
Small Business Expensing Permanency Act of 2003
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
H.R.3610, "Food and Drug Import Safety Act of 2007"; S.242, H.R.380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2638, "Department of Homeland Security Appropriations Act, 2008"; H.AMDT 734 to HR3161 and S1859 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to importation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public
Expanding Education for Military Families Act of 2003
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
HR1585 and S567, "National Defense Authorization Act for FY2008" ; HR3222 and HR2764, "Department of Defense Appropriations Act, 2008: provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
H.R.3610, "Food and Drug Import Safety Act of 2007"; S.242, H.R.380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2638, "Department of Homeland Security Appropriations Act, 2008"; H.AMDT 734 to HR3161 and S1859 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to importation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
HR1585 and S567, "National Defense Authorization Act for FY2008" ; HR3222 and HR2764, "Department of Defense Appropriations Act, 2008: provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.
S184 And HR753, Safe Import Act Of 2005, Provisions And Issues Related To The Safety Of Imported Pharmaceuticals From Other Countries; HCR Provisions Or Amendments Relating To Importation On Senate Budget Resolution S. Con Res 83; HR4157, Better Health Information System Act, Provisions And Issues Related To The Stark Anti-Kickback Restrictions And Coordination And Planning For Interoperability Of Health IT (Information Technology). HR4157 Better Health Information System Act, Provisions And Issues Related The Safe Harbor Protections And Healthcare Price Transparency; S1955, Health Insurance Marketplace Modernization And Affordability Act;
National Defense Authorization Act for Fiscal Year 2007
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Provisions And Issues Related To Direction Of The Department Of Defense To Conduct A Pharmaceutical Over-The-Counter Therapeutic Substitution Demonstration Project, And Provisions Requiring The Department Of Defense To Establish A Disease Management Pilot Project At Selected Military Medical Treatment Facilities. S2507, National Defense Authorization Act For Fy 2007, Provisions And Issues Related To The Extension Of The Definiation Of Depot Procurement And Payment By Pharmaceutical Companies Of Rebates On Procuremnets By Federal Agencies, And Hr1815, National Defense Authorization Acr For Fy2007;
Foreign Investment and National Security Act of 2006
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Provisions Related To The Reform Of The Cfius Process, Including HR5337 National Security Foreign Investment Reform And Strengthened Transparency Act Of 2006; S3549 Foreign Investment And National Security Act Of 2006.
Provisions Relating To Patent Reform, Including HR 5096; S3818, The Patent Reform Act Of 2006; HR2795, Patent Reform Act Of 2005 And Other Patent Reform Proposals.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2009 · third_quarter · Q3
Provisions and issues related to coverage and payment pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to the importation of prescription drugs, issues related to cancer awareness and access to treatment, issues related to the coordination of care, and issues related to the 340B federal Safety Net Drug Pricing Program including such provisions included or under consideration in draft health care reform legislation "America's Healthy Future Act," and in HR3200 "America's Affordable Health Choices Act," and S1679 "Affordable Health Choices Act"; General issues related to the Medicare Part D program and issues related to awareness of atrial fibrillation and access to treatment.; All provisions of HR2502 "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes"; All provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2009 · second_quarter · Q2
Coverage and payment issues for pharmaceuticals under consideration for draft legislation for healthcare reform; issues related to the importation of prescription drugs in amendments to the draft legislation "Affordable Health Choices Act"; issues related to a regulatory pathway and reimburesment for follow on biologics, including such provisions in HR 1548 "Pathway for Biosimilars Act"; issues related to awareness of the company's Access to Medicines Program; all provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"; general issues related to the Medicare Part D program
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009" and HR1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR1260 "The Patent Reform Act of 2009"
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2008 · fourth_quarter · Q4
Issues related to awareness of and the quality of care for Deep Vein Thrombosis (DVT); standards for and funding of health information technology that would impact access to pharmaceutical care and treatment; healthcare reform that would impact the access to pharmaceutical care and treatment; issues related to the final regulations implementing those provisions of the "National Defense Authorization Act for FY 2008" related to TRICARE retail pharmacy sales.
reimbursement of Medicare Part B drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2008 · third_quarter · 3A
Cancer awareness, including women's cancer program; issues related to Deep Vein Thrombosis (DVT) awareness and quality of care; issues related to diabetes care in the federal healthcare programs; and issues related to men's health
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2008 · second_quarter · 2A
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call to Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System; issues related to the 340B federal drug pricing program.
compendia coverage of Medicare Part B drugs, including such related provisions in HR 3162 "Children's Health and Medicare Protection Act of 2007"
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2008 · first_quarter · 1A
Deep Vein Thrombosis awareness; issues related to follow-on biologics including all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S 567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR 4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
compendia coverage of Medicare Part B drugs, including such related provisions in HR 3162 "Children's Health and Medicare Protection Act of 2007"; Deep Vein Thrombosis issues related to Medicare Part A Regulation and the Medicare Part D Call Letter.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2008 · third_quarter · Q3
Cancer awareness, including women's cancer program; issues related to Deep Vein Thrombosis (DVT) awareness and quality of care; issues related to diabetes care in the federal healthcare programs; and issues related to men's health
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2008 · second_quarter · Q2
Deep Vein Thrombosis (DVT) awareness and quality of care; DVT Call To Action; provisions related to transition rules for follow-on biologics in S 623 "Access to Life-Saving Medicine Act", HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; awareness of the Together Rx Access program; awareness of the Access to Medicines Program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 4896 "National Defense Authorization Act for FY2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.; issues related to the 340B federal drug pricing program
compendia coverage of Medicare Part B drugs, including such related provisions in HR 3162 "Children's Health and Medicare Protection Act of 2007"
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2008 · first_quarter · Q1
compendia coverage of Medicare Part B drugs, including such related provisions in HR 3162 "Children's Health and Medicare Protection Act of 2007"; Deep Vein Thrombosis issues related to Medicare Part A Regulation and the Medicare Part D Call Letter.
Deep Vein Thrombosis awareness; issues related to follow-on biologics included all related provisions in HR 1956 "Patient Protection and Innovative Biologic Medicines Act of 2007", and S 1695 "Biologics Price Competition and Innovation Act of 2007"; comparative effectiveness; the Together Rx Access program; HR 1585 and S567, "National Defense Authorization Act for FY2008"; HR 3222 and HR 2764, "Department of Defense Appropriations Act, 2008", and HR4986, "National Defense Authorization Act for Fiscal Year 2008": provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2007 · year_end · YY
HR4104 and HR2642, "Military Construction and Veterans Affairs and Related Agencies Appropriations Act of 2008" (provisions related to the quality of healthcare delivered by the Veterans Health Administration)
Issues related to Thailand issuing compulsory license of innovative pharmaceuticals.
Issues related to follow on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Administration Revitalization Act" and HR3580, "The Food and Drug Administration Amendment Act of 2007," and HR3610 "Food and Drug Import Safety Act of 2007"; HR1038 "Access to Life-Saving Medicine Act" and S1695 "Biologics Price Competition and Innovation Act of 2007" All provisions.
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2007 · year_end · RA
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2007 · year_end · RA
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2007 · mid_year · MM
Issues related to the reform of the CFIUS review process, including HR556 "National Security Foreign Investment Reform and Strengthened Transparency" and S1610 "Foreign Investment and National Security Act of 2007"
HR1585 "National Defense Authorization Act for FY2008" (issues and provisions related to reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System); isues related to TRICARE and the Task Force on the Future of Military Healthcare
Issues related to Thailand issuing compulsory license of innovative pharmaceuticals.
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2006 · year_end · YY
Provisions Related To The Reform Of The Cfius Process, Including HR5337 National Security Foreign Investment Reform And Strengthened Transparency Act Of 2006; S3549 Foreign Investment And National Security Act Of 2006.
Coding And Reimbursement For Medicare Part B Products; Deficit Reduction Act Of 2005, Implementation Of Provisions Related To Medicaid Reforms. Provisions Or Amendments Relating To The Government Noninterference Provision Of The Medicare Modernization Act; Medicare Part D Implementation, Including Issues Related To Patient Assistance Programs And True Out Of Pocket Expeditures;
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2006 · mid_year · RA
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.3610, "Food and Drug Import Safety Act of 2007"; S.242, H.R.380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2638, "Department of Homeland Security Appropriations Act, 2008"; H.AMDT 734 to HR3161 and S1859 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to importation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public
S1145 and HR 1908, "The Patent Reform Act of 2007" All provisions
Issues related to importation/reimportation of prescription drugs in and the Labor HHS-Education Appropriations Act.
Issues and provisions related to the closure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007 and S1607, "The Children's Health Insurance Program Reauthorization Act of 2007." coding and reimbursement or coverage issues for Medicare
HR1585 and S567, "National Defense Authorization Act for FY2008" ; HR3222 and HR2764, "Department of Defense Appropriations Act, 2008: provisions related to procurement and reimbursement for services by the TRICARE system and the quality of healthcare delivered by the Defense Health System.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
S1145 and HR1908 "Patent Reform Act of 2007" (all provisions)
HR2642 "Military Construction and Veterans Affairs Appropriations Act of 2008" (issues/provisions related to the quality of healthcare delivered by the Veterans Health Administration
HR2138 "Investment in America Act of 2007" (all provisions)
Issues related to follow on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Revitalization Act of 2007" and HR2900 "The Food and Drug Administration Amendments Act of 2007"
coding and reimbursement or coverage issues for Medicare Part B products and Medicare Part D services, preventative health screenings and assessments, and obesity drugs; issues related to DVT prevention and awareness, including draft legislation "Deep Vein Thrombosis Prevention Act of 2007" ; issues related to osteoporosis prevention and awareness. HR4 and S3 "Medicare Prescription Drug Price Negotiation Act Of 2007" (All Provisions); issues and provisions related to the closure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007" and S1607 "The Children's Health Insurance Program Reauthorization Act of 2007";
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
Provisions And Issues Related To Direction Of The Department Of Defense To Conduct A Pharmaceutical Over-The-Counter Therapeutic Substitution Demonstration Project, And Provisions Requiring The Department Of Defense To Establish A Disease Management Pilot Project At Selected Military Medical Treatment Facilities. S2507, National Defense Authorization Act For Fy 2007, Provisions And Issues Related To The Extension Of The Definiation Of Depot Procurement And Payment By Pharmaceutical Companies Of Rebates On Procuremnets By Federal Agencies, And Hr1815, National Defense Authorization Acr For Fy2007;
And Discussions Related To The Impact Of Access Restrictions In The VA National Formulary. Discussions Related To Congressional Intent As Expressed In The Veterans Healthcare Act Of 1992, The Medicare Prescription Drug, Improvement And Modernization Act Of 2003, And The Tricare Program Regarding Provisions Related To The Procurement And Reimbursement For Prescription Drugs;
S184 And HR753, Safe Import Act Of 2005, Provisions And Issues Related To The Safety Of Imported Pharmaceuticals From Other Countries; HCR Provisions Or Amendments Relating To Importation On Senate Budget Resolution S. Con Res 83; HR4157, Better Health Information System Act, Provisions And Issues Related To The Stark Anti-Kickback Restrictions And Coordination And Planning For Interoperability Of Health IT (Information Technology). HR4157 Better Health Information System Act, Provisions And Issues Related The Safe Harbor Protections And Healthcare Price Transparency; S1955, Health Insurance Marketplace Modernization And Affordability Act;
Provisions Relating To R&D Tax Credit, Including HR 6111, The Tax Relief & Health Care Act Of 2006; HR 5970, The Estate Tax & Extension Of Tax Relief Act Of 2006; HR 2830, Pension Security & Transparency Act Of 2005.
Provisions Relating To Patent Reform, Including HR 5096; S3818, The Patent Reform Act Of 2006; HR2795, Patent Reform Act Of 2005 And Other Patent Reform Proposals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE